Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NRG1 intronic transcript 3 (NRG1-IT3) is a non-protein-coding RNA transcript transcribed from an intronic region of the *Neuregulin 1* (*NRG1*) gene. This transcript does not encode a protein and there is no published experimental evidence about its function, disease role, or relevance as a drug target. It is not considered a canonical therapeutic target, and there is no indication of its use in biomarker assays, drug discovery, or clinical practice. Its entry in gene annotation databases appears to be based on RNA-seq or genome annotation, not on demonstrated biological or clinical importance[5]. *Note:* If you are seeking information on protein-coding NRG1 isoforms (such as Neuregulin 1 type III), these have important, experimentally supported roles in cell signaling and neurological/oncological diseases[1][2][3][4], but NRG1-IT3 is distinct and currently has no such accepted function or target designation.
None
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NRG1 intronic transcript 3 (non-protein coding) (NRG1-IT3).